4//SEC Filing
KING PHARMACEUTICALS INC 4
Accession 0001209191-06-053650
CIK 0001047699operating
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 7:50 PM ET
Size
5.7 KB
Accession
0001209191-06-053650
Insider Transaction Report
Form 4
GREETHAM ELIZABETH M
Director
Transactions
- Award
Common Stock
2006-10-02+1,177→ 6,927 total
Footnotes (1)
- [F1]Represents a grant of restricted stock units, with a restricted period that ends on the first to occur of the following events: (1) April 28, 2007; (2) the director, standing for reelection, is not reelected; (3) the director completes his or her term of office after declining to stand for reelection; (4) the director completes his or her term of office after not being nominated to stand for reelection; (5) the director completes his or her term of office, having been ineligible to stand for reelection under term limit provisions then in effect. The restricted period lapses immediately upon a change of control. This grant was approved by the Board of Directors of King Pharmaceuticals, Inc. ("King") on August 2, 2006 as disclosed in the Current Report on Form 8-K filed by King on August 8, 2006.
Documents
Issuer
KING PHARMACEUTICALS INC
CIK 0001047699
Entity typeoperating
IncorporatedTN
Related Parties
1- filerCIK 0001047699
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 7:50 PM ET
- Size
- 5.7 KB